ID JVE367 AC CVCL_EG29 SY JVE-367 DR cancercelllines; CVCL_EG29 DR DSMZ; ACC-829 DR DSMZCellDive; ACC-829 DR GEO; GSM1655611 DR GEO; GSM1655633 DR Wikidata; Q54899185 RX PubMed=26894854; RX PubMed=28931069; CC Doubling time: ~4-5 days (DSMZ=ACC-829). CC Microsatellite instability: Stable (MSS) (PubMed=26894854). CC Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26894854). CC Omics: Genomics; DNA methylation analysis. CC Omics: Transcriptomics; Microarray. CC Omics: Variations; SNP array analysis. CC Derived from site: In situ; Intestine, ileocecal junction; UBERON=UBERON_0001073. ST Source(s): DSMZ=ACC-829; PubMed=26894854 ST Amelogenin: X ST CSF1PO: 11,12 (PubMed=26894854) ST CSF1PO: 12 (DSMZ=ACC-829) ST D13S317: 9 ST D16S539: 13 ST D18S51: 19 ST D19S433: 14 ST D21S11: 31.2 (DSMZ=ACC-829) ST D21S11: 33.2 (PubMed=26894854) ST D2S1338: 19,20 ST D3S1358: 15,17 ST D5S818: 12 ST D7S820: 9,11 ST D8S1179: 11,13 ST FGA: 26 ST Penta D: 8 ST Penta E: 7 ST TH01: 6,9.3 ST TPOX: 10 ST vWA: 21 DI NCIt; C96157; Colorectal large cell neuroendocrine carcinoma DI ORDO; Orphanet_100080; Neuroendocrine tumor of the colon OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 61Y CA Cancer cell line DT Created: 13-07-16; Last updated: 10-04-25; Version: 17 // RX PubMed=26894854; DOI=10.18632/oncotarget.7391; PMCID=PMC4924731; RA Boot A., van Eendenburg J.D.H., Crobach S., Ruano D., Speetjens F., RA Calame J., Oosting J., Morreau H., van Wezel T.; RT "Characterization of novel low passage primary and metastatic RT colorectal cancer cell lines."; RL Oncotarget 7:14499-14509(2016). // RX PubMed=28931069; DOI=10.1371/journal.pone.0184900; PMCID=PMC5607170; RA Boot A., Oosting J., van Eendenburg J.D.H., Kuppen P.J.K., Morreau H., RA van Wezel T.; RT "Methylation associated transcriptional repression of ELOVL5 in novel RT colorectal cancer cell lines."; RL PLoS ONE 12:e0184900.1-e0184900.16(2017). //